A new proposed bill in Congress will seek to offer insurance to players in the marijuana industry.

The bill, called the Clarifying Law Around Insurance Marijuana (CLAIM) Act, was introduced on Monday (July 29) and sponsored by representatives Nydia M. Velázquez (D-NY) and Steve Stivers (R-OH).

The bipartisan CLAIM Act would create a federal safe pass so insurers can engage the marijuana industry, despite the federal illegality of operations related to the plant.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

“Without this legislation, insurers will understandably be reticent to insure businesses operating in the cannabis sector,” Velázquez said in an announcement. “This means a legal cannabis distributor whose product is ruined from a flood or fire could lose all their capital and their livelihood.

Due to the federal rules surrounding the marijuana industry, operators must carry on business operations without any insurance for their crops and land.

Despite the rush in legal cannabis programs at the state level, marijuana businesses face a slew of challenges from the lack of federal clarity.

A variety of proposed bills have appeared that would offer relief to the marijuana industry either via banking or insurance options, since the drug remains illegal in the eyes of the federal government.

In March, the House Financial Services Committee voted in favor of the Secure and Fair Enforcement Banking Act of 2019, otherwise known as the SAFE Banking Act. After being introduced and recommended by the Congressional committee, the bill awaits activity from the Senate.

On July 23, the Senate Banking Committee held a hearing, “Challenges for Cannabis and Banking: Outside Perspectives,” and listened to testimony on the needs of the cannabis industry.

According to a report from Marijuana Moment, the CLAIM Act resembles a recently announced Senate bill from Senator Bob Menendez (D-NJ).

The bill from Velázquez would also look to create a brand new study from the Government Accountability Office about the challenges women and minority entrepreneurs face when trying to enter the industry.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less